We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+10.98%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.7B
AUM Growth
-$4.56M
(-0.01%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-8.5%
Top 10 Holdings %
Top 10 Hldgs %
19.9%
Holding
801
New
88
Increased
169
Reduced
396
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$165M |
| 2 |
Costco
COST
|
+$134M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$126M |
| 4 |
Johnson Controls International
JCI
|
+$121M |
| 5 |
3M
MMM
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$136M |
| 3 |
Marathon Petroleum
MPC
|
+$123M |
| 4 |
CenterPoint Energy
CNP
|
+$123M |
| 5 |
Under Armour
UAA
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.42% |
| 2 | Healthcare | 16.85% |
| 3 | Financials | 12.9% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Industrials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Fortive
FTV
$17.9B
| $26.1M | 0.06% |
+541,805
| New | +$24.5M |
|
327
Jack Henry & Associates
JKHY
$10.9B
| $26M | 0.06% |
178,810
-9,788
| -5% | -$1.43M |
|
328
ResMed
RMD
$30.6B
| $26M | 0.06% |
167,590
-7,075
| -4% | -$1.02M |
|
|
NVRO
329
DELISTED
NEVRO CORP.
NVRO
| $25.9M | 0.06% |
220,000
-30,000
| -12% | -$2.97M |
|
330
Cintas
CTAS
$81.9B
| $25.8M | 0.06% |
384,000
-27,200
| -7% | -$1.79M |
|
331
Idexx Laboratories
IDXX
$44.1B
| $25.8M | 0.06% |
98,919
-5,700
| -5% | -$1.5M |
|
332
Weyerhaeuser
WY
$18B
| $25.7M | 0.06% |
850,300
-541,200
| -39% | -$15.7M |
|
333
Peloton Interactive
PTON
$2.77B
| $25.7M | 0.06% |
903,500
-1,425,000
| -61% | -$38.4M |
|
334
Dollar Tree
DLTR
$24.4B
| $25.7M | 0.06% |
272,791
-225,207
| -45% | -$23.6M |
|
|
ANSS
335
DELISTED
Ansys
ANSS
| $25.5M | 0.06% |
99,200
-2,200
| -2% | -$520K |
|
|
CXO
336
DELISTED
CONCHO RESOURCES INC.
CXO
| $25.2M | 0.06% |
288,200
+48,900
| +20% | +$3.53M |
|
337
Xenon Pharmaceuticals
XENE
$6.06B
| $25.2M | 0.06% |
1,925,000
+625,000
| +48% | +$6.57M |
|
338
MSCI
MSCI
$41.6B
| $25.1M | 0.06% |
97,300
-4,700
| -5% | -$1.15M |
|
|
BLUE
339
DELISTED
bluebird bio
BLUE
| $25M | 0.06% |
+22,002
| New | +$23.9M |
|
340
Hershey
HSY
$35.2B
| $25M | 0.06% |
170,085
-8,200
| -5% | -$1.22M |
|
341
Ball Corp
BALL
$17.3B
| $25M | 0.06% |
386,097
+35,400
| +10% | +$2.4M |
|
342
Ventas
VTR
$48B
| $24.6M | 0.06% |
426,700
-20,600
| -5% | -$1.29M |
|
343
SS&C Technologies
SSNC
$18.1B
| $24.6M | 0.06% |
400,000
+57,584
| +17% | +$3.23M |
|
344
CDW
CDW
$18.9B
| $24.4M | 0.06% |
170,500
-117,900
| -41% | -$15.6M |
|
345
Champion Homes
SKY
$4.37B
| $24M | 0.06% |
758,572
+158,572
| +26% | +$4.94M |
|
346
McCormick & Company Non-Voting
MKC
$13.7B
| $24M | 0.06% |
282,830
-13,600
| -5% | -$1.13M |
|
347
Equity Residential
EQR
$24.9B
| $23.9M | 0.06% |
295,795
-42,903
| -13% | -$3.65M |
|
348
AerCap
AER
$23.7B
| $23.9M | 0.06% |
388,424
+170,616
| +78% | +$10M |
|
349
CBRE Group
CBRE
$42.5B
| $23.6M | 0.06% |
385,100
-18,500
| -5% | -$1.02M |
|
350
OneMain Financial
OMF
$7.2B
| $23.6M | 0.06% |
559,458
-136,342
| -20% | -$5.51M |
|
Similar funds
Adage Capital Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Adage Capital Partners held 801 positions worth $40.7B, down 0.01% from $40.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Adage Capital Partners withdrew a net $3.46B in Q4 2019, closing 90 positions and reducing 396 holdings. Its most notable exit was Celgene Corp, an estimated $1.48B position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $142M.
- Adage Capital Partners's largest Q4 2019 buy was Bristol-Myers Squibb: 2,207,539 shares worth $142M.
- Adage Capital Partners added most to RTX Corp in Q4 2019, an estimated $165M increase.
- Adage Capital Partners's biggest Q4 2019 reduction was Apple, cutting an estimated $136M.
- Adage Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $1.48B.
- Adage Capital Partners's ten largest holdings make up 20% of its $40.7B portfolio in Q4 2019.
- Adage Capital Partners opened 88 new positions and closed 90 in Q4 2019.
- Adage Capital Partners's portfolio value fell 0.01% quarter-over-quarter to $40.7B.
Based on Adage Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.